ATE362359T1 - Amoxicillintrihydrat - Google Patents

Amoxicillintrihydrat

Info

Publication number
ATE362359T1
ATE362359T1 AT04722271T AT04722271T ATE362359T1 AT E362359 T1 ATE362359 T1 AT E362359T1 AT 04722271 T AT04722271 T AT 04722271T AT 04722271 T AT04722271 T AT 04722271T AT E362359 T1 ATE362359 T1 AT E362359T1
Authority
AT
Austria
Prior art keywords
trihydrate
product
amoxicillint
relates
preferably less
Prior art date
Application number
AT04722271T
Other languages
English (en)
Inventor
Jan Groenendaal
Everardus Leenderts
Van Der Does
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45007138&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE362359(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Application granted granted Critical
Publication of ATE362359T1 publication Critical patent/ATE362359T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
AT04722271T 2003-03-21 2004-03-22 Amoxicillintrihydrat ATE362359T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US45618803P 2003-03-21 2003-03-21
US45618703P 2003-03-21 2003-03-21
EP03100731 2003-03-21
EP03100732 2003-03-21

Publications (1)

Publication Number Publication Date
ATE362359T1 true ATE362359T1 (de) 2007-06-15

Family

ID=45007138

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04722271T ATE362359T1 (de) 2003-03-21 2004-03-22 Amoxicillintrihydrat

Country Status (14)

Country Link
US (1) US20060172987A1 (de)
EP (2) EP1610766B1 (de)
JP (2) JP4949827B2 (de)
CN (2) CN102260278B (de)
AT (1) ATE362359T1 (de)
BR (2) BRPI0408568A (de)
CY (1) CY1106809T1 (de)
DE (1) DE602004006507T2 (de)
ES (1) ES2286627T3 (de)
MX (2) MXPA05010104A (de)
PL (1) PL1610766T3 (de)
PT (1) PT1610766E (de)
SI (1) SI1610766T1 (de)
WO (3) WO2004082661A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0408568A (pt) * 2003-03-21 2006-03-21 Dsm Ip Assets Bv triidrato de amoxicilina
US7534781B2 (en) * 2003-03-21 2009-05-19 Dsm Ip Assets B.V. Crystalline amoxicillin trihydrate powder
US8198446B2 (en) * 2007-05-21 2012-06-12 Toray Industries, Inc. Crystalline micropowder particles
US7985791B1 (en) 2008-02-22 2011-07-26 Lords Additives LLC Incorporation of SBP and ulexite into composites
EP2778171A1 (de) * 2013-03-15 2014-09-17 Synbias Pharma Ltd. Kristallines Monohydrat von Epirubicinhydrochlorid
CN103145733B (zh) * 2013-03-20 2014-02-26 四川省惠达药业有限公司 一种阿莫西林化合物及该化合物和克拉维酸钾的药物组合物
EP3041845A1 (de) * 2013-09-03 2016-07-13 DSM Sinochem Pharmaceuticals Netherlands B.V. Mikronisiertes amoxicillin
CN104059086B (zh) * 2014-06-19 2016-04-13 河南牧翔动物药业有限公司 一种阿莫西林晶体及其制备方法
CN104099396B (zh) * 2014-07-22 2016-03-23 石药集团中诺药业（石家庄）有限公司 一种直通法制备阿莫西林的工艺
WO2017186864A1 (en) 2016-04-27 2017-11-02 Sandoz Ag Enzymatic process for the production of beta-lactam antibiotics in the presence of particulate inoculum
CN109867687B (zh) * 2017-12-05 2021-08-17 上海朝瑞化工有限公司 一种高水溶性阿莫西林及其制备方法
CN111518119B (zh) * 2020-05-26 2021-12-21 联邦制药(内蒙古)有限公司 一种阿莫西林连续结晶工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1532672A (en) * 1976-07-20 1978-11-15 Bristol Myers Co Process for the preparation of amoxicillin trihydrate
JPS5583789A (en) * 1978-12-18 1980-06-24 Bristol Myers Co Preparation of penicillin
JPS6052751B2 (ja) * 1981-04-21 1985-11-21 富山化学工業株式会社 新規な結晶形を有するセフアレキシン１水和物
WO1994017800A1 (en) * 1993-02-15 1994-08-18 Gist-Brocades B.V. AN IMPROVED β-LACTAM ANTIBIOTIC COMPOSITION
GB9423459D0 (en) * 1994-11-21 1995-01-11 Biochemie Gmbh Silylation process
TWI225402B (en) * 1996-03-13 2004-12-21 Biochemie Gmbh Auxiliary-free agglomerates
AU9540898A (en) * 1997-08-29 1999-03-22 Dsm N.V. Granules free of excipients
US20020137926A1 (en) * 1998-06-01 2002-09-26 Smithkline Beecham Corporation Process for preparing crystalline salts of amoxycillin
EP1165049B2 (de) * 1999-04-01 2011-07-06 DSM IP Assets B.V. Agglomerate durch kristallisation
AT412213B (de) * 2000-05-30 2004-11-25 Sandoz Ag Verfahren zur trocknung von amoxicillin oder amoxicillin-hältigen, oralen, festen pharmazeutischen zusammensetzungen unter verwendung eines gases mit einer definierten gasfeuchte
BRPI0408568A (pt) * 2003-03-21 2006-03-21 Dsm Ip Assets Bv triidrato de amoxicilina

Also Published As

Publication number Publication date
DE602004006507D1 (en) 2007-06-28
JP4949827B2 (ja) 2012-06-13
PT1610766E (pt) 2007-08-01
BRPI0408403A (pt) 2006-03-21
CY1106809T1 (el) 2012-05-23
CN1761457A (zh) 2006-04-19
CN1761457B (zh) 2010-05-12
EP1808166A1 (de) 2007-07-18
WO2004082663A1 (en) 2004-09-30
DE602004006507T2 (de) 2008-01-31
WO2004082661A1 (en) 2004-09-30
EP1610766A1 (de) 2006-01-04
MXPA05010102A (es) 2005-11-23
WO2004082662A1 (en) 2004-09-30
JP4949826B2 (ja) 2012-06-13
US20060172987A1 (en) 2006-08-03
MXPA05010104A (es) 2005-11-23
JP2006523188A (ja) 2006-10-12
PL1610766T3 (pl) 2007-08-31
CN102260278B (zh) 2015-05-06
SI1610766T1 (sl) 2007-10-31
ES2286627T3 (es) 2007-12-01
BRPI0408568A (pt) 2006-03-21
CN102260278A (zh) 2011-11-30
JP2006520765A (ja) 2006-09-14
EP1610766B1 (de) 2007-05-16

Similar Documents

Publication Publication Date Title
CY1106809T1 (el) Τριενυδρη αμοξικιλλινη
BR0203040A (pt) Processo para preparação de um ácido silìcico de precipitação hidrófobo com elevado grau de brancura e absorção de umidade extremamente baixa
DE50310614D1 (de) Verfahren zur herstellung von c13-alkoholgemischen
FI916187A0 (fi) Piidioksidia sisältävä tuote ja menetelmä sen valmistamiseksi
BR9910297A (pt) Novos análogos graxos para o tratamento de diabetes
FI906438A0 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi
PT791037E (pt) Processo para estabilizacao de produtos de gelatina
BRPI0408631A (pt) composição protéica em pó
ATE401309T1 (de) Verwendung von 2-fuoro-3-ketoestern zur herstellung von 3-fuoro-6,7,8,9-tetrahydro-4h- pyrimidoä1,2-aüpyrimidin-4-onen
CY1110913T1 (el) Παραγωγα 2-πυρρολιδιν-2-υλο-[1,3,4]-οξαδιαζολης και η χρησιμοποιηση τους σαν αντικαταθλιπτικα
EP1568729A4 (de) Polysiloxan mit phosphorylcholingruppe und herstellungsverfahren dafür
DE69231815D1 (de) Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren
DE69331003T2 (de) Kristalle von derivaten von chinozon carbonsäure-hydraten
BR0108446A (pt) Produtos à base de uva, fortificados com cálcio e processos para prepará-los
DE69925992D1 (de) VERFAHREN ZUR HERSTELLUNG VON 5-HYDROXYBENZO[b]THIOPHEN-3-CARBONSÄURE
BRPI0411087A (pt) aperfeiçoamentos em ou relacionados a compostos orgánicos
ATE206922T1 (de) Verwendung von amlexanox zur herstellung eines arzneimittels zur behandlung von aphtösen ulcera
DE69912650D1 (de) Düngemittel-granulations-zusätze enthaltend magnesium- und kalzium- karbonat und sulfat
DE59808752D1 (de) Verfahren zur Herstellung von wasserfreiem Natriumsulfid
DE50205794D1 (de) Verfahren zur herstellung fester formulierungen von natrium-3-hydroxy-3-methylbutyrat
BRPI0413564A (pt) formulação de tratamento de madeira
DE60139391D1 (de) Ierte nukleinsäuremoleküle und deren verwendungen
AU2003273860A1 (en) Carboxylic acid derivatives containing phosphorous groups and organically polymerisable groups
JPS56159253A (en) Stabilized composition of resin containing halogen
ATE286879T1 (de) Synthesezwischenprodukte zur herstellung von vitamin d-derivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1610766

Country of ref document: EP